Skip to main content

Taxotere MDL Update: Discovery stage in progress

Taxotere MDL Update: Discovery stage in progress

Taxotere MDL Update: Discovery stage in progress

Introduction

Taxotere: – MDL No. 2740: in Re Taxotere (Docetaxel) Products Liability Litigation was created on October 4, 2016, under Judge Kurt D. Engelhardt in the Eastern District of Louisiana; the bellwether trial dates are set for January 28, 2019; April 8, 2019; July 15, 2019; and November 4, 2019. There are 7,500 cases filed under this MDL as per the 26th January Joint Status Report submitted by both the parties. The Plaintiffs of the currently pending cases were ordered to produce product information as per the Case Management Report dated 12th January, to be submitted within a period of 15 days from the Order entry date. The rest of the Plaintiffs will have 30 days in hand once a Short Form Complaint has been filed by them with the Court.

A permanent alopecia lawsuit was filed against Sanofi over its chemotherapy drug’s side effects by a Pennsylvania woman in the U.S. District Court for the Eastern District of Louisiana. Allegations included including failure to warn, negligence, fraudulent misrepresentation and concealment, and several others.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Talcum Powder Cancer Settlement Talks Begin Sept. 4

Categories: Talcum

Representatives of Johnson & Johnson (J&J) and attorneys for tens of thousands of plaintiffs involved in talcum powder lawsuits are scheduled to meet in September 2025 in an…

Tepezza Hearing Loss Trials Delayed Until Aug 2026

Categories: Tepezza

A series of Tepezza hearing loss lawsuits, which were expected to go before juries next year, will now be delayed. The U.S. District Judge overseeing the multidistrict…

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

✍️ 100% FREE — 60 mins Legal Transcription and 2 Demand Letters!                 
🔒 No AI. No Risk. No Contract. 100% HIPAA-Compliant, Done by Attorneys & Doctors.

Only 06 Slots left for Law Firms—Offer Ends Sep 30!